Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Camp4 Therapeutics (CAMP) FCF Margin (2024 - 2025)

Camp4 Therapeutics' FCF Margin history spans 3 years, with the latest figure at 1816.67% for Q4 2025.

  • For Q4 2025, FCF Margin rose 358829.0% year-over-year to 1816.67%; the TTM value through Dec 2025 reached 852.0%, up 620367.0%, while the annual FY2025 figure was 852.0%, 620367.0% up from the prior year.
  • FCF Margin for Q4 2025 was 1816.67% at Camp4 Therapeutics, up from 1414.59% in the prior quarter.
  • Across five years, FCF Margin topped out at 14143.37% in Q4 2023 and bottomed at 1771.63% in Q4 2024.
  • The 3-year median for FCF Margin is 1051.32% (2025), against an average of 1731.1%.
  • The largest annual shift saw FCF Margin tumbled -1591500bps in 2024 before it skyrocketed 358829bps in 2025.
  • A 3-year view of FCF Margin shows it stood at 14143.37% in 2023, then crashed by -113bps to 1771.63% in 2024, then soared by 203bps to 1816.67% in 2025.
  • Per Business Quant, the three most recent readings for CAMP's FCF Margin are 1816.67% (Q4 2025), 1414.59% (Q3 2025), and 688.04% (Q2 2025).